These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 8425224

  • 1. Pristane induces an indomethacin inhibitable inflammatory influx of CD4+ T cells and IFN-gamma production in plasmacytoma-susceptible BALB/cAnPt mice.
    McDonald AH, Degrassi A.
    Cell Immunol; 1993 Jan; 146(1):157-70. PubMed ID: 8425224
    [Abstract] [Full Text] [Related]

  • 2. Specific pathogen-free BALB/cAn mice are refractory to plasmacytoma induction by pristane.
    Byrd LG, McDonald AH, Gold LG, Potter M.
    J Immunol; 1991 Nov 15; 147(10):3632-7. PubMed ID: 1682379
    [Abstract] [Full Text] [Related]

  • 3. Prostaglandin E2-mediated dysregulation of proinflammatory cytokine production in pristane-induced lupus mice.
    Chae BS, Shin TY, Kim DK, Eun JS, Leem JY, Yang JH.
    Arch Pharm Res; 2008 Apr 15; 31(4):503-10. PubMed ID: 18449509
    [Abstract] [Full Text] [Related]

  • 4. Disposition of the plasmacytomagenic alkane pristane (2,6,10,14-tetramethylpentadecane) in mice.
    Janz S, Shacter E.
    Cancer Biochem Biophys; 1995 Jun 15; 15(1):25-34. PubMed ID: 8536217
    [Abstract] [Full Text] [Related]

  • 5. The bisphosphonate zoledronic acid inhibits the development of plasmacytoma induced in BALB/c mice by intraperitoneal injection of pristane.
    Avcu F, Ural AU, Yilmaz MI, Ozcan A, Ide T, Kurt B, Yalcin A.
    Eur J Haematol; 2005 Jun 15; 74(6):496-500. PubMed ID: 15876253
    [Abstract] [Full Text] [Related]

  • 6. Detection of immunoglobulin/c-myc recombinations in mice that are resistant to plasmacytoma induction.
    Müller JR, Jones GM, Potter M, Janz S.
    Cancer Res; 1996 Jan 15; 56(2):419-23. PubMed ID: 8542601
    [Abstract] [Full Text] [Related]

  • 7. Identification of two genes on chromosome 4 that determine resistance to plasmacytoma induction in mice.
    Potter M, Mushinski EB, Wax JS, Hartley J, Mock BA.
    Cancer Res; 1994 Feb 15; 54(4):969-75. PubMed ID: 8313388
    [Abstract] [Full Text] [Related]

  • 8. Perturbation of B cell genesis in the bone marrow of pristane-treated mice. Implications for plasmacytoma induction.
    Rico-Vargas SA, Potter M, Osmond DG.
    J Immunol; 1995 Mar 01; 154(5):2082-91. PubMed ID: 7868885
    [Abstract] [Full Text] [Related]

  • 9. Induction of plasmacytomas with silicone gel in genetically susceptible strains of mice.
    Potter M, Morrison S, Wiener F, Zhang XK, Miller FW.
    J Natl Cancer Inst; 1994 Jul 20; 86(14):1058-65. PubMed ID: 8021954
    [Abstract] [Full Text] [Related]

  • 10. Pristane-induced arthritis in mice. V. Susceptibility to pristane-induced arthritis is determined by the genetic regulation of the T cell repertoire.
    Wooley PH, Sud S, Whalen JD, Nasser S.
    Arthritis Rheum; 1998 Nov 20; 41(11):2022-31. PubMed ID: 9811058
    [Abstract] [Full Text] [Related]

  • 11. BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocations.
    Silva S, Kovalchuk AL, Kim JS, Klein G, Janz S.
    Cancer Res; 2003 Dec 15; 63(24):8656-63. PubMed ID: 14695177
    [Abstract] [Full Text] [Related]

  • 12. Plasmacytoma-refractory BALB/cAnPt mice have naive T cell and highly specific B cell responses to antigen.
    McDonald AH, Byrd LG, Mainhart CR, Sopher J, Smith-Gill SJ.
    Mol Immunol; 1996 Oct 15; 33(15):1183-96. PubMed ID: 9070667
    [Abstract] [Full Text] [Related]

  • 13. Lipopolysaccharide and pristane-induced peritoneal exudate requirements for plasma tumor cell colony formation.
    Platica M, Bojko C, Clincea R, Hollander V.
    J Natl Cancer Inst; 1982 Feb 15; 68(2):325-8. PubMed ID: 6950164
    [Abstract] [Full Text] [Related]

  • 14. Peritoneal plasmacytomagenesis in mice: comparison of different pristane dose regimens.
    Potter M, Wax JS.
    J Natl Cancer Inst; 1983 Aug 15; 71(2):391-5. PubMed ID: 6576197
    [Abstract] [Full Text] [Related]

  • 15. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells.
    Bohn E, Autenrieth IB.
    J Immunol; 1996 Feb 15; 156(4):1458-68. PubMed ID: 8568248
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of plasmacytoma development in BALB/c mice by indomethacin.
    Potter M, Wax JS, Anderson AO, Nordan RP.
    J Exp Med; 1985 May 01; 161(5):996-1012. PubMed ID: 3989472
    [Abstract] [Full Text] [Related]

  • 17. Indomethacin is a potent inhibitor of pristane and plastic disc induced plasmacytomagenesis in a hypersusceptible BALB/c congenic strain.
    Potter M, Wax J, Jones GM.
    Blood; 1997 Jul 01; 90(1):260-9. PubMed ID: 9207461
    [Abstract] [Full Text] [Related]

  • 18. Differential susceptibility of BALB/c and DBA/2 cells to plasmacytoma induction in reciprocal chimeras.
    Silva S, Sugiyama H, Babonits M, Wiener F, Klein G.
    Int J Cancer; 1991 Sep 09; 49(2):224-8. PubMed ID: 1879968
    [Abstract] [Full Text] [Related]

  • 19. Genetics of susceptibility to pristane-induced plasmacytomas in BALB/cAn: reduced susceptibility in BALB/cJ with a brief description of pristane-induced arthritis.
    Potter M, Wax JS.
    J Immunol; 1981 Oct 09; 127(4):1591-5. PubMed ID: 7276572
    [Abstract] [Full Text] [Related]

  • 20. Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility.
    Zhang SL, DuBois W, Ramsay ES, Bliskovski V, Morse HC, Taddesse-Heath L, Vass WC, DePinho RA, Mock BA.
    Mol Cell Biol; 2001 Jan 09; 21(1):310-8. PubMed ID: 11113205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.